A Safety and Efficacy Study of OnabotulinumtoxinA in Upper Facial Rhytides
Status:
Completed
Trial end date:
2016-04-20
Target enrollment:
Participant gender:
Summary
This is a safety and efficacy study of onabotulinumtoxinA in subjects with upper facial
rhytides (forehead lines, glabellar lines, lateral canthal lines [crow's feet lines]).
Phase:
Phase 3
Details
Lead Sponsor:
Allergan
Treatments:
abobotulinumtoxinA Botulinum Toxins Botulinum Toxins, Type A incobotulinumtoxinA onabotulinumtoxinA